ERIS Lifescience

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE406M01024
  • NSEID: ERIS
  • BSEID: 540596
INR
1,557.95
-28.3 (-1.78%)
BSENSE

Dec 16

BSE+NSE Vol: 70.4 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryERIS Lifescience VS Pharmaceuticals & Biotechnology
 
1D
-1.78%
-0.63%
1W
-8.44%
0.02%
1M
0.51%
0.14%
YTD
13.81%
8.37%
1Y
8.89%
3.59%
3Y
132.76%
38.05%
5Y
183.13%
81.46%
10Y
%
232.15%
  • Stock Absolute Returns
  • Absolute Returns
stock-summaryPrice + Dividend
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0.46%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-6.2%
0%
-6.2%
6 Months
-16.06%
0%
-16.06%
1 Year
8.89%
0.55%
9.44%
2 Years
78.42%
0.81%
79.23%
3 Years
132.76%
1.11%
133.87%
4 Years
123.12%
1.95%
125.07%
5 Years
183.13%
3.36%
186.49%

Latest dividend: 7.35 per share ex-dividend date: Feb-13-2025

stock-summaryReturn Quartiles
What is a Quartile?

Quartile analysis gives a quick view of the performance of the stock with its peers and with the overall market. Companies are bucketed in 4 Quartiles as per their total returns generated; with each quartile consisting of 25% of the companies in the category.


Example: If there are 20 companies in an industry, the top 5 return giving companies would be bucketed in 1st quartile, next 5 companies in 2nd quartile and so on

Return Quartiles - by Closest Peers stock-summary
Inconsistent Performance

ERIS Lifesciences Ltd has not been a consistent performer in the YTD and longer periods

3
Quartile
quartile-3
QTD
-1.92%
2
Quartile
quartile-2
Jun-Sep
-5.49%
3
Quartile
quartile-3
Mar-Jun
19.11%
2
Quartile
quartile-2
YTD
9.18%
3
Quartile
quartile-3
2024
50.33%
3
Quartile
quartile-3
2023
41.07%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Industry stock-summary
Good Performer

ERIS Lifesciences Ltd has been in the First and Second Quartile in the YTD and longer periods

2
Quartile
quartile-2
QTD
-1.92%
2
Quartile
quartile-2
Jun-Sep
-5.49%
2
Quartile
quartile-2
Mar-Jun
19.11%
1
Quartile
quartile-1
YTD
9.18%
2
Quartile
quartile-2
2024
50.33%
2
Quartile
quartile-2
2023
41.07%
Click on any of the quartiles for detailed breakdown
Return Quartiles - by Market Cap stock-summary
Inconsistent Performance

ERIS Lifesciences Ltd has not been a consistent performer in the YTD and longer periods

2
Quartile
quartile-2
QTD
-1.92%
2
Quartile
quartile-2
Jun-Sep
-5.49%
2
Quartile
quartile-2
Mar-Jun
19.11%
1
Quartile
quartile-1
YTD
9.18%
2
Quartile
quartile-2
2024
50.33%
3
Quartile
quartile-3
2023
41.07%
Click on any of the quartiles for detailed breakdown
stock-summaryRisk Adjusted Returns v/s
Risk Adjusted Returns v/s stock-summary
stock-summaryReturns Beta
Returns Beta
Icon
Beta has not been calculated since enough price history is not available